Sorrento Therapeutics Inc (SRNE)

[dia76ca]

All studies start with mice. So far Salicyn-30 looks interesting. There are lots of anti-virals out there. Are they better? Are they as good? This is what interests me..."Moreover, based on their mechanism of action, Salicyn-30 and other lead compounds may be equally effective against RECENT EMERGING SARS-CoV-2 VARIANTS. The combination of anti-SARS-CoV-2 activity, cytokine inhibitory activity, VARIANT INDIFFERENCE and a previously established favorable pharmacokinetic profile for the lead Salicyn-30 renders salicylanilides in general, and Salicyn-30 in particular, as promising therapeutics for COVID-19."
Time will tell!

The full paper is available to read at: https://pubs.acs.org/doi/full/10.1021/acsinfecdis.1c00253.